Wilmot Director to Lead National Lymphoma Research Board
January 28, 2008
Richard I. Fisher, M.D., director of the James P. Wilmot Cancer Center, was elected chair of the Lymphoma Research Foundation’s Scientific Advisory Board.
Fisher, an international expert in lymphoma care and research, will work with leading lymphoma experts from throughout the country to provide strategic direction for the Foundation’s scientific agenda. The Lymphoma Research Foundation is the nation's largest voluntary health organization devoted to funding lymphoma research and providing patients and health care professionals with critical information on the disease
“Lymphoma research is considered the ‘Rosetta Stone’ of cancer research because it has helped unlock the mysteries of several other types of cancer,” Fisher said. “On a personal and professional basis, it is very rewarding to be actively involved with an organization that funds cutting-edge research with such far reaching applications.”
Fisher is chair of the Lymphoma Committee of the Southwest Oncology Group, one of the largest National Cancer Institute-supported clinical trials cooperative groups, and a member of the American Society of Clinical Oncology, American Association for Cancer Research, American Society of Hematology, American Association for Cancer Research, and European Society for Medical Oncology.
A graduate of Harvard Medical School, he completed an internship and residency at Massachusetts General Hospital. Fisher’s research centers on the biology and treatment of lymphoma, cancers derived from white blood cells, and he has led national and international studies in Hodgkin’s disease and non-Hodgkin’s lymphoma.